Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIII.a

Bronchospasm - Wheezing - Asthma

Publications

Gouel-Chéron A, Neukirch C, Aubier B, Montravers P, Nicaise P, Chollet-Martin S, Mertes PM, Aubier M, Longrois D

Anaphylactic bronchospasm during general anesthesia is not related to asthma.

Allergy 2015 Apr;70;453-6 — 2015 Apr — 453-6

Bishop MJ, O'Donnell JT, Salemi JR

Mivacurium and bronchospasm.

Anesthesia and analgesia 2003 Aug;97;484-5, table of contents — 2003 Aug — 484-5, table of contents

Rajchert DM, Pasquariello CA, Watcha MF, Schreiner MS

Rapacuronium and the risk of bronchospasm in pediatric patients.

Anesthesia and analgesia 2002 Mar;94;488-93; table of contents — 2002 Mar — 488-93; table of contents

Kron SS

Severe bronchospasm and desaturation in a child associated with rapacuronium.

Anesthesiology 2001 May;94;923-4 — 2001 May — 923-4